<DOC>
	<DOCNO>NCT01856946</DOCNO>
	<brief_summary>Childhood obesity rapidly grow epidemic US world . Current estimate suggest 30 % nation 's child either overweight ot obese . Obesity major risk factor towards development insulin resistance , , turn major risk factor development type 2 diabetes . Prior research suggest vitamin D therapy may safe , inexpensive , effective method reduce insulin resistance person 's risk develop diabetes . The investigator ' prior study show daily 4,000 IU vitamin D therapy safe effective method improve insulin resistance base calculation call HOMA-IR . The next step identify whether vitamin D truly improve insulin resistance use oral glucose tolerance testing ( OGTT ) , good real-life measure insulin resistance compare previously use HOMA-IR .</brief_summary>
	<brief_title>Effect Vitamin D Supplementation Oral Glucose Tolerance Among Obese Adolescents</brief_title>
	<detailed_description>The investigator intend recruit 20 obese adolescent subject PI 's obesity clinic participate study . Investigators expect 5 drop , therefore leave 15 subject complete study . Eligible assent subject ( consent parent ) admit Pediatric Procedure Suite MU Women 's Children 's Hospital . They IV place arm nurse experience work child . The subject blood draw IV check vitamin D level , insulin , glucose , c-peptide level ( another marker insulin status ) . The subject ask drink 75 gram glucose solution . Additional blood drawn IV site check glucose , insulin , c-peptide level 30 minute , 60 minute , 90 minute , 120 minute . A total 30 mL ( 2 tablespoon ) blood draw day . The subject IV remove discharged take two 2,000 IU vitamin D3 pill ( total 4,000 IU ) daily six month . At routine 3 month clinical visit , subject test routine , standard care , basic metabolic profile ( BMP ) 4 ml blood ( le 1 teaspoon ) assess high calcium level , potential complication vitamin D therapy . In investigator ' previous study adolescent take 4,000 IU vitamin D daily six month , subject develop high calcium level . At six month , subject return Pediatric procedure suite another OGTT lab via IV describe .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Obese adolescent ( BMI &gt; 85th percentile age ) 919 year age attend ADOBE clinic University Missouri 25OH vitamin D level within past 3 month use vit D supplement standard multivitamin preparation ( i.e. , receive vit D &gt; 1000 IU/d ) use medication interfere vit D metabolism ( e.g. , anticonvulsive ) history hepatic renal disorder , hypercalciuria , hypercalcemia undergo UV radiation medical therapy pregnancy ; cigarette smoking ; current use tan bed current type 2 diabetes current antihyperglycemic medication use ( e.g . metformin , insulin ) less one month prior initial OGTT .</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>